Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Does CG0070 have better efficacy than Ruvidar PDT?

<< Previous

Bullboard Posts

Next >>

Comment by digitalstoneon Jan 27, 2024 7:58pm

128 Views

Post# 35848935

RE:Does CG0070 have better efficacy than Ruvidar PDT?

Eoganacht wrote: It's too early to tell as CG Oncology has not revealed 9, 12, and 15 month data. It looks close. They definitely require a lot more treatments to get this result.

3 mths 6 mths 9 mths 12 mths 15 mths

CG0070
standalone
phase 3 68.20% 63.60% ? ? ?

Ruvidar PDT
optimized 62% 60% 45% 40% 39%